Start Your Risk-Free Trial

Zileuton — Discount Pricing

Zileuton is not confirmed for no-additional-cost pricing. Discount pricing may be available; confirm the price with the dispensing pharmacy.

Zileuton Pricing

Pricing typePrice
TheDrugClubDiscount pricing may be available
Typical Retail$133.00

Discount pricing may be available; confirm the price with the dispensing pharmacy.

About Zileuton

Zileuton is a prescription medication. Ask your doctor if Zileuton is right for you.

How to Check Zileuton Pricing

  1. Join TheDrugClub for $19.95/month
  2. Receive your member card by email
  3. Present your card at a participating pharmacy
  4. Check active-formulary eligibility or available discount pricing

Zileuton at Participating Pharmacies

Pharmacy participation and fulfillment options vary. Present your membership card and confirm current pricing before filling.

Other medications in Respiratory

About Zileuton

Zileuton is a prescription medication primarily used to manage chronic asthma. It works by targeting specific inflammatory pathways in the body, helping to reduce the frequency and severity of asthma attacks. For those prescribed zileuton, navigating its cost can be a concern, but TheDrugClub offers pathways to potential savings and benefits on this important medication.

The information above is for educational purposes only and does not constitute medical advice. Consult your healthcare provider before making medication decisions.

What Zileuton is approved for (FDA label)

ZYFLO is indicated for the prophylaxis and chronic treatment of asthma in adults and children 12 years of age and older.

Source: Read the full FDA label on DailyMed. Label effective date: November 30, 2025.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Adverse reactions for Zileuton (FDA label)

Clinical Studies : A total of 5542 patients have been exposed to zileuton in clinical trials, 2252 of them for greater than 6 months and 742 for greater than 1 year. Adverse events most frequently occurring (frequency ≥3%) in ZYFLO-treated patients and at a frequency greater than placebo-treated patients are summarized in Table 2. Proportion of Patients Experiencing Adverse Events in Placebo-Controlled Studies in Asthma Less common adverse events occurring at a frequency of greater than 1% and more commonly in ZYFLO-treated patients included: arthralgia, chest pain, conjunctivitis, constipation, dizziness, fever, flatulence, hypertonia, insomnia, lymphadenopathy, malaise, neck pain/rigidity, nervousness, pruritus, somnolence, urinary tract infection, vaginitis, and vomiting.

Source: FDA prescribing information (DailyMed). Set ID: aee65202-fddb-497f-9f11-17cc727cb157. SPL document ID: d49e40c7-0635-4220-8b0a-c5068116ee17. Label effective date: November 30, 2025. Read the full label.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Start Your Risk-Free Trial
Start Your Risk-Free Trial